Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system?

Expert Opinion on Drug Delivery

Volumn 13, Issue 10, 2016, Pages 1341-1343

  Tosi, Giovanni ^a   Belletti, Daniela ^a   Pederzoli, Francesca ^a   Ruozi, Barbara ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Apoferritin; drug carries; drug delivery; protein; translatability

Indexed keywords

APOFERRITIN; NANOCAGE; NANOCARRIER;

BIOSAFETY; DRUG DELIVERY SYSTEM; EDITORIAL; HUMAN; NANOENCAPSULATION; NANOPHARMACEUTICS; PH;

EID: 84983800218     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1080/17425247.2016.1224848     Document Type: Editorial

References (11)

1. D.He, J.Marles-Wright Ferritin family proteins and their use in bionanotechnology. N Biotechnol. 2015;32:651–657.
2. P.Ponka, D.R.Richardson. Can ferritin provide iron for hemoglobin synthesis? Blood. 1997;89:2611–2613.
3. E.Y.Chi, S.Krishnan, T.W.Randolph, et al. Physical stability of proteins in aqueous solution:mechanism and driving forces in nonnative protein aggregation. Pharm Res. 2003;20:1325–1336.
4. A.Maham, Z.Tang, H.Wu, et al. Protein-based nanomedicine platforms for drug delivery. Small. 2009;5:1706–1721.•• A complete review on novel nanomedicies produced with protein.
5. A.S.De Groot, D.W.Scott. Immunogenicity of protein, therapeutics. Trends Immunol. 2007;28:482–490.• A good overview of the one the most important limitation in application of proteins in therapy.
6. J.A.Lofgren, I.Wala, E.Koren, et al. Detection of neutralizing anti-therapeutic protein antibodies in serum or plasma samples containing high levels of the therapeutic protein. J Immunol Methods. 2006;308:101–108.
7. M.Wadhwa, A.Meager, P.Dilger, et al. Neutralizing antibodies to granulocyte–macrophage colony stimulating factor (GM–CSF), interleukin-1α (IL-1α) and interferon-α (IFN-α), but not other cytokines in human immunoglobulin preparations. Immunology. 2000;99:113–123.
8. M.A.Kilic, E.Ozlu, S.Calis. A novel protein-based anticancer drug encapsulating nanosphere:apo-doxorubicin complex. J Biomed Nanotechnol. 2012;8:508–514.
9. X.-T.Ji, L.Huang, H.-Q.Huang. Construction of nanometer cisplatin core-ferritin (NCC-F) and proteomic analysis of gastric cancer cell apoptosis induced with cisplatin released from the NCC-F. J Proteomics. 2012;75:3145–3157.
10. L.Zhang, L.Li, A.Di Penta, et al. H-chain ferritin:a natural nuclei targeting and bioactive delivery nanovector. Adv Healthc Mater. 2015;4:1305–1310.
11. X.Li, L.H.Qiu, P.Zhu, et al. Epidermal growth factor-ferritin h-chain protein nanoparticles for tumor active targeting. Small. 2012;8:2505–2514.•• One of the few examples of apoferritin use in tumor targeting.